HOTH Insider Trading

Insider Ownership Percentage: 10.71%
Insider Buying (Last 12 Months): $11,800.00
Insider Selling (Last 12 Months): $0.00

Hoth Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Hoth Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Hoth Therapeutics Share Price & Price History

Current Price: $3.35
Price Change: Price Decrease of -0.06 (-1.76%)
As of 12/8/2022 01:00 AM ET

This chart shows the closing price history over time for HOTH up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Hoth Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/19/2022Robb KnieCEOBuy10,000$0.39$3,900.00828,259View SEC Filing Icon  
9/19/2022Robb KnieCEOBuy10,000$0.39$3,900.00828,259View SEC Filing Icon  
9/16/2022Robb KnieCEOBuy10,000$0.40$4,000.00818,259View SEC Filing Icon  
5/26/2020Anthony HayesMajor ShareholderSell400,000$1.25$500,000.001,130,674View SEC Filing Icon  
See Full Table
Elon Musk Sees Serious Crisis
When Tesla's Elon Musk says there's a major shortage of a key material used in electric vehicles...and says prices for this material are "CRAZY"...you can bet there's an incredible investment opportunity in that crisis.
Discover how you can take advantage of lithium

SEC Filings (Institutional Ownership Changes) for Hoth Therapeutics (NASDAQ:HOTH)

4.31% of Hoth Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at HOTH by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Hoth Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2022Vanguard Group Inc.942,305$0.33M0.0%+23.2%72.485%Search for SEC Filing on Google Icon
11/14/2022Renaissance Technologies LLC136,045$47K0.0%-13.5%10.563%Search for SEC Filing on Google Icon
8/13/2022Virtu Financial LLC138,213$58K0.0%+453.2%0.429%Search for SEC Filing on Google Icon
8/13/2022Renaissance Technologies LLC157,245$66K0.0%+77.9%0.488%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC88,400$61K0.0%-47.1%0.274%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.764,646$0.53M0.0%+7.7%2.374%Search for SEC Filing on Google Icon
8/16/2021State Street Corp27,100$43K0.0%N/A0.114%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC79,571$0.13M0.0%+323.4%0.333%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.706,195$1.13M0.0%+650.7%2.958%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC79,758$0.16M0.0%+137.4%0.334%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC131,773$0.26M0.0%N/A0.552%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC79,758$0.16M0.0%+137.4%0.334%Search for SEC Filing on Google Icon
5/17/2021Armistice Capital LLC2,270,000$4.47M0.1%N/A9.509%Search for SEC Filing on Google Icon
5/14/2021XTX Topco Ltd12,888$25K0.0%N/A0.054%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC221,000$0.44M0.0%+40.6%0.926%Search for SEC Filing on Google Icon
5/13/2021Bank of New York Mellon Corp26,555$52K0.0%N/A0.111%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.24,502$48K0.0%-23.8%0.108%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC157,190$0.37M0.0%+98.5%1.170%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.32,146$76K0.0%+20.3%0.239%Search for SEC Filing on Google Icon
9/10/2020Two Sigma Securities LLC10,768$28K0.0%N/A0.080%Search for SEC Filing on Google Icon
8/14/2020Sabby Management LLC68,681$0.18M0.0%N/A0.512%Search for SEC Filing on Google Icon
8/12/2020Goldman Sachs Group Inc.16,027$41K0.0%N/A0.119%Search for SEC Filing on Google Icon
8/11/2020Magnus Financial Group LLC13,000$34K0.0%N/A0.097%Search for SEC Filing on Google Icon
8/3/2020Game Plan Financial Advisors LLC10,750$28K0.0%N/A0.080%Search for SEC Filing on Google Icon
7/16/2020Wedbush Securities Inc.22,856$59K0.0%N/A0.170%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Hoth Therapeutics logo
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-ALZ for the treatment and/or prevention of Alzheimer's or other neuroinflammatory diseases; HT-003 to treat inflammatory bowel diseases, as well as acne and psoriasis; HT-004 for treatment of asthma and allergies using inhalational administration; HT-006 to treat lung diseases resulting from bacterial infections; and HT-002, a novel peptide for treating COVID-19. The company is also developing BioLexa Platform, a proprietary, patented, drug compound platform which is in phase I clinical trial for the treatment of eczema; and HT-005 for treating patients with lupus. The company has license agreements with the George Washington University; the University of Maryland; Isoprene Pharmaceuticals, Inc.; the North Carolina State University; Chelexa BioSciences, Inc.; Zylö Therapeutics, Inc., and the University of Cincinnati. It also has a research collaboration agreement with Weill Cornell Medicine to develop HT-003. Hoth Therapeutics, Inc. was incorporated in 2017 and is headquartered in New York, New York.
Read More on Hoth Therapeutics

Today's Range

Now: $3.35
Low: $3.35
High: $3.41

50 Day Range

MA: $5.67
Low: $3.35
High: $8.84

52 Week Range

Now: $3.35
Low: $3.35
High: $43.75

Volume

7,195 shs

Average Volume

22,326 shs

Market Capitalization

$4.36 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.68

Who are the company insiders with the largest holdings of Hoth Therapeutics?

Hoth Therapeutics' top insider investors include:
  1. Robb Knie (CEO)
Learn More about top insider investors at Hoth Therapeutics.

Who are the major institutional investors of Hoth Therapeutics?

Hoth Therapeutics' top institutional investors include:
  1. Vanguard Group Inc. — 72.49%
  2. Renaissance Technologies LLC — 10.56%
Learn More about top institutional investors of Hoth Therapeutics stock.

Which institutional investors are selling Hoth Therapeutics stock?

During the previous quarter, HOTH stock was sold by these institutional investors:
  1. Renaissance Technologies LLC

Which institutional investors are buying Hoth Therapeutics stock?

During the last quarter, HOTH stock was bought by institutional investors including:
  1. Vanguard Group Inc.